Theravance Biopharma (TBPH) Inventory Average (2014 - 2018)

Theravance Biopharma (TBPH) has 5 years of Inventory Average data on file, last reported at $17.9 million in Q3 2018.

• On a quarterly basis, Inventory Average rose 30.84% year-over-year to $17.9 million in Q3 2018; TTM through Sep 2018 was $17.9 million, a 30.84% increase from a year earlier, with the FY2017 full-year figure at $14.5 million, up 30.71% from the prior year.
• Inventory Average for Q3 2018 stood at $17.9 million, up from $17.6 million in the prior quarter.
• Over the last five years, Inventory Average for TBPH reached as high as $17.9 million in Q3 2018 and fell as low as $9.6 million in Q2 2016.
• Historically, Inventory Average has averaged $13.2 million across 5 years, with a median of $12.7 million in 2017.
• Across the five-year window, Inventory Average retreated 22.8% in 2016 and jumped 38.6% in 2018, its largest moves.
• Year by year, Inventory Average stood at $13.8 million in 2014, then slipped by 19.98% to $11.1 million in 2015, then climbed by 11.53% to $12.4 million in 2016, then rose by 29.91% to $16.0 million in 2017, then grew by 11.66% to $17.9 million in 2018.
• Per Business Quant data, the three most recent Inventory Average figures were $17.9 million in Q3 2018, $17.6 million in Q2 2018, and $17.0 million in Q1 2018.